Food Allergy Epidemiology Forecast Insight

DelveInsight’s ‘Food Allergy (FA)–Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Food Allergy (FA), historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2018–2030

Food Allergy (FA) Disease Understanding

Food Allergy (FA) is an adverse health effect arising from a specific immune response that occurs reproducibly on exposure to a given food. Food allergens are the parts of food or ingredients within food (usually proteins) that are recognized by immune cells. When an immune cell binds to a food allergen, a reaction occurs that causes the symptoms of Food Allergy (FA). “Allergy” and “allergic disease” refer to conditions that involve changes to the immune system.

 

These immune system changes fall into two categories: Immunoglobulin E (IgE) mediated and Non-IgE-mediated.

 

The symptoms of food allergies range from mild discomfort to severe, life-threatening reactions, which require immediate medical intervention. Symptoms may be triggered in the skin (itching, redness, swelling), gastrointestinal tract (pain, vomiting, diarrhoea, itching and swelling of oral cavity), respiratory tract (itching and swelling of the nose and throat, asthma), eyes (itching and swelling), and/or cardiovascular system (e.g. chest pain, abnormal heart rhythm).

 

Diagnosis of a Food Allergy (FA) relies on patient history and physical exam. The most common diagnosis method for Food Allergy (FA) according to World Allergy Organization (WAO) include Skin prick tests (SPT), which is the preferred testing method in those patients with a history compatible with food allergies; double blind placebo-controlled food challenge (DBPCFC), which is the preferred test to diagnose Food Allergy (FA); the in vitro diagnostics can help to identify cross-reactive allergens between pollen and foods, or foods and latex, and the atopy patch test (APT) is an epicutaneous skin test in which allergens commonly associated with IgE reactions can be used.

 

The treatment of Food Allergy (FA) relies on avoidance of the foods to which an individual is allergic, as therapeutic intervention (tertiary prevention) in patients with Food Allergy (FA). Unfortunately, severe reactions such as anaphylaxis may occur despite best efforts in avoidance. Epinephrine is the first-line medication for the treatment of anaphylaxis

Food Allergy (FA) Epidemiology

The Food Allergy (FA) epidemiology division provides insights about the historical and current patient pool along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

 

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Food Allergy (FA) epidemiology segmented as the Prevalence of Food Allergy (FA), Prevalence of Food Allergy (FA) based on Etiology-specific Factors, Age-specific Prevalence of Food Allergy (FA). The report includes the Prevalent scenario of Food Allergy (FA) in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.

Country Wise- Food Allergy (FA) Epidemiology

The epidemiology segment also provides the Food Allergy (FA) epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

  • The total prevalent population of Food Allergy (FA) associated in 7MM countries was estimated to be 56,849,000 cases in 2020 and expected to increase at a CAGR of 0.40% for the study period, i.e., 2018–2030.
  • As per the estimates, United States has the highest prevalent population of Food Allergy (FA) in 7MM.
  • Among the EU5 countries, Spain had the highest prevalent population of Food Allergy (FA). On the other hand, UK had the lowest number of case, 2,015,000 cases in 2020.

Scope of the Report

  • Food Allergy (FA) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns
  • Food Allergy (FA) Epidemiology Report and Model provide an overview of the risk factors and global trends of Food Allergy (FA) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight into the historical and forecasted patient pool of Food Allergy (FA) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps recognize the growth opportunities in the 7MM concerning the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Food Allergy (FA)
  • The report provides the segmentation of the Food Allergy (FA) epidemiology by prevalent Cases of Food Allergy (FA) in 7MM
  • The report provides the segmentation of the Food Allergy (FA) epidemiology by Prevalence of Food Allergy (FA), Prevalence of Food Allergy (FA) based on Etiology specific factors, Age-specific cases of Food Allergy (FA) in 7MM

Report Highlights

  • 10-year Forecast of Food Allergy (FA) epidemiology
  • 7MM Coverage
  • Total Prevalent Cases of Food Allergy (FA)
  • Prevalent Cases of Food Allergy (FA) based on Etiology-specific Factors
  • Gender-specific Prevalence of Food Allergy (FA)

KOL Views

We interview KOLs, and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

  • What will be the growth opportunities in the 7MM concerning the patient population about Food Allergy (FA)?
  • What are the key Findings of Food Allergy (FA) epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2021–2030)?
  • What would be the total number of patients with Food Allergy (FA) across the 7MM during the forecast period (2021–2030)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2021–2030)?
  • At what CAGR the patient population is expected to grow by 7MM during the forecast period (2021–2030)?
  • What are the disease risk, burden, and unmet needs of Food Allergy (FA)?
  • What are the currently available treatments for Food Allergy (FA)?

Reasons to buy

The Food Allergy (FA) Epidemiology report will allow the user to -

  • Develop business strategies by understanding the trends shaping and driving the global Food Allergy (FA) market
  • Quantify patient populations in the global Food Allergy (FA) market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Food Allergy (FA) therapeutics in each of the markets covered
  • Understand the magnitude of Food Allergy (FA) population by its prevalent cases
  • Understand the magnitude of Food Allergy (FA) population by its clinical manifestation specific cases
  • The Food Allergy (FA) epidemiology report and model was written and developed by Masters and PhD level epidemiologists
  • The Food Allergy (FA) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights

2. Report Introduction

3. Food Allergy (FA) Market Overview at a Glance

3.1. Market Share (%) Distribution of Food Allergy (FA) in 2018

3.2. Market Share (%) Distribution of Food Allergy (FA) in 2030

4. Executive Summary of Food Allergy (FA)

5. Organizations contributing towards Food Allergy (FA)

6. Disease Background and Overview

6.1. Introduction

6.2. Etiology

6.3. Clinical Manifestations

6.4. Subtypes of Food Allergy (FA)

6.5. Diagnosis

7. Management and Treatment

7.1. Guidelines

7.2. Japanese Guidelines for Food allergies

7.2.1. Symptom Severity and Treatment

7.2.1.1. Grading symptom severity

7.2.1.2. Treatment based on symptom severity

7.2.1.3. Evaluation of organ-specific symptoms

7.2.2. Management of Anaphylaxis in a Health Care Setting

7.2.2.1. Confirmation of vital signs

7.2.2.2. Ensuring staff and treatment by a team

7.2.2.3. Intramuscular injection of adrenaline

7.2.2.4. Body position of the anaphylaxis patients

7.2.2.5. Administration of oxygen

7.2.2.6. Securing the intravenous infusion route and rapid rehydration

7.2.2.7. Cessation of respiration

7.2.2.8. Measurement of vital signs: Re-evaluation

7.2.3. Contraindication of adrenaline

7.3. The European Academy of Allergy and Clinical Immunology (EAACI) Guidelines

7.4. American Guidelines for the Diagnosis and Management of Food allergies

8. Epidemiology and Patient Population

8.1. Key Findings

8.3. 7MM Total Prevalent Patient Population of Food Allergy (FA)

8.4. Assumption and Rationale

8.5. The United States

8.5.1. Prevalent cases of Food Allergy (FA) in the United States

8.5.2. Prevalent Cases of Food Allergy (FA) based on Etiology-specific factors in the United States

8.5.3. Age-specific Prevalence of Food Allergy (FA) in the United States

8.6. EU5

8.6.1. Germany

8.6.1.1. Prevalent cases of Food Allergy (FA) in Germany

8.6.1.2. Prevalent Cases of Food Allergy (FA) based on Etiology-specific factors in Germany

8.6.1.3. Age-specific Prevalence of Food Allergy (FA) in Germany

8.6.2. France

8.6.2.1. Prevalent cases of Food Allergy (FA) in France

8.6.2.2. Prevalent Cases of Food Allergy (FA) based on Etiology-specific factors in France

8.6.2.3. Age-specific Prevalence of Food Allergy (FA) in France

8.6.3. Italy

8.6.3.1. Prevalent cases of Food Allergy (FA) in Italy

8.6.3.2. Prevalent Cases of Food Allergy (FA) based on Etiology-specific factors in Italy

8.6.3.3. Age-specific Prevalence of Food Allergy (FA) in Italy

8.6.4. Spain

8.6.4.1. Prevalent cases of Food Allergy (FA) in Spain

8.6.4.2. Prevalent Cases of Food Allergy (FA) based on Etiology-specific factors in Spain

8.6.4.3. Age-specific Prevalence of Food Allergy (FA) in Spain

8.6.5. United Kingdom

8.6.5.1. Prevalent cases of Food Allergy (FA) in United Kingdom

8.6.5.2. Prevalent Cases of Food Allergy (FA) based on Etiology-specific factors in United Kingdom

8.6.5.3. Age-specific Prevalence of Food Allergy (FA) in the United Kingdom

8.7. Japan

8.7.1. Prevalent cases of Food Allergy (FA) in Japan

8.7.2. Prevalent Cases of Food Allergy (FA) based on Etiology-specific factors in Japan

8.7.3. Age-specific Prevalence of Food Allergy (FA) in Japan

9. Patient Journey

10. Case Reports

11. KOL views

12. Appendix

12.1. Bibliography

12.2. Report Methodology

13. DelveInsight Capabilities

14. Disclaimer

15. About DelveInsight

List of Table

Table 1: Summary of Food Allergy (FA), Market, Epidemiology, and Key Events (2018–2030)

Table 2: Organizations contributing towards Food Allergies

Table 3: Classification of Food Allergies

Table 4: Total Prevalent Patient Population of Food Allergy (FA) in 7MM (2018–2030)

Table 5: Prevalent cases of Food Allergy (FA) in the United States (2018–2030)

Table 6: Prevalent Cases of Food Allergy (FA) based on Etiology-specific factor in the United States in (2018–2030)

Table 7: Age-specific Prevalence of Food Allergy (FA) in the United States (2018–2030)

Table 8: Prevalent cases of Food Allergy (FA) in Germany (2018–2030)

Table 9: Prevalent Cases of Food Allergy (FA) based on Etiology-specific factor in Germany (2018–2030)

Table 10: Age-specific Prevalence of Food Allergy (FA) in Germany (2018–2030)

Table 11: Prevalent cases of Food Allergy (FA) in France (2018–2030)

Table 12: Prevalent Cases of Food Allergy (FA) based on Risk Factors in France (2018–2030)

Table 13: Age-specific Prevalence of Food Allergy (FA) in France (2018–2030)

Table 14: Prevalent cases of Food Allergy (FA) in Italy (2018–2030)

Table 15: Prevalent Cases of Food Allergy (FA) based on Etiology-specific factors in Italy (2018–2030)

Table 16: Age-specific Prevalence of Food Allergy (FA) in Italy (2018–2030)

Table 17: Prevalent cases of Food Allergy (FA) in Spain (2018–2030)

Table 18: Prevalent Cases of Food Allergy (FA) based on Etiology-specific factors in Spain (2018–2030)

Table 19: Gender-specific Prevalence of Food Allergy (FA) in Spain (2018–2030)

Table 20: Prevalent cases of Food Allergy (FA) in United Kingdom (2018–2030)

Table 21: Prevalent Cases of Food Allergy (FA) based on Etiology-specific factors in United Kingdom in (2018–2030)

Table 22: Age-specific Prevalence of Food Allergy (FA) in the United Kingdom (2018–2030)

Table 23: Prevalent cases of Food Allergy (FA) in Japan (2018–2030)

Table 24: Prevalent Cases of Food Allergy (FA) based on Etiology-specific factors in Japan (2018–2030)

Table 25: Age-specific Prevalence of Food Allergy (FA) in Japan (2018–2030)

Table 26: Ligelizumab (QGE031), Clinical Trial Description, 2021

Table 27: Viaskin Peanut, Clinical Trial Description, 2021

Table 28: INP20, Clinical Trial Description, 2021

Table 29: CNP-201, Clinical Trial Description, 2021

Table 30: VE416, Clinical Trial Description, 2021

Table 31: AR201, Clinical Trial Description, 2021

Table 32: Dupilumab, Clinical Trial Description, 2021

Table 33: Omalizumab, Clinical Trial Description, 2021

Table 34: CA002, Clinical Trial Description, 2021

Table 35: 7 Major Market Size of Food Allergy (FA) in USD Million (2018–2030)

Table 36: 7 Major Market Size of Food Allergy (FA) by Therapies in USD Million (2018–2030)

Table 37: United States Market Size of Food Allergy (FA) in USD Million (2018–2030)

Table 38: United States Market Size of Food Allergy (FA) by Therapies in USD Million (2018–2030)

Table 39: Germany Market Size of Food Allergy (FA) in USD Million (2018–2030)

Table 40: Germany Market Size of Food Allergy (FA) by Therapies in USD Million (2018–2030)

Table 41: France Market Size of Food Allergy (FA) in USD Million (2018–2030)

Table 42: France Market Size of Food Allergy (FA) by Therapies in USD Million (2018–2030)

Table 43: Italy Market Size of Food Allergy (FA) in USD Million (2018–2030)

Table 44: Italy Market Size of Food Allergy (FA) by Therapies in USD Million (2018–2030)

Table 45: Spain Market Size of Food Allergy (FA) in USD Million (2018–2030)

Table 46: Spain Market Size of Food Allergy (FA) by Therapies in USD Million (2018–2030)

Table 47: United Kingdom Market Size of Food Allergy (FA) in USD Million (2018–2030)

Table 48: United Kingdom Market Size of Food Allergy (FA) by Therapies in USD Million (2018–2030)

Table 49: Japan Market Size of Food Allergy (FA) in USD Million (2018–2030)

Table 50: Japan Market Size of Food Allergy (FA) by Therapies in USD Million (2018–2030)

List of Figures

Figure 1: Immune Cell Function

Figure 2: Total Prevalent Population of Food Allergy (FA) in 7MM (2018–2030)

Figure 3: Prevalent cases of Food Allergy (FA) in the United States (2018–2030)

Figure 4: Prevalent Cases of Food Allergy (FA) based on Etiology-specific factor in the United States (2018–2030)

Figure 5: Age-specific Prevalence of Food Allergy (FA) in the United States (2018–2030)

Figure 6: Prevalent cases of Food Allergy (FA) in Germany (2018–2030)

Figure 7: Prevalent Cases of Food Allergy (FA) based on Etiology-specific factor in Germany (2018–2030)

Figure 8: Age-specific Prevalence of Food Allergy (FA) in Germany (2018–2030)

Figure 9: Prevalent cases of Food Allergy (FA) in France (2018–2030)

Figure 10: Prevalent Cases of Food Allergy (FA) based on Etiology-specific factor in France (2018–2030)

Figure 11: Age-specific Prevalence of Food Allergy (FA) in France (2018–2030)

Figure 12: Prevalent cases of Food Allergy (FA) in Italy (2018–2030)

Figure 13: Prevalent Cases of Food Allergy (FA) based on Etiology-specific factors in Italy (2018–2030)

Figure 14: Age-specific Prevalence of Food Allergy (FA) in Italy (2018–2030)

Figure 15: Prevalent cases of Food Allergy (FA) in Spain (2018–2030)

Figure 16: Prevalent Cases of Food Allergy (FA) based on Etiology-specific factors in Spain (2018–2030)

Figure 17: Age-specific Prevalence of Food Allergy (FA) in Spain (2018–2030)

Figure 18: Prevalent cases of Food Allergy (FA) in United Kingdom (2018–2030)

Figure 19: Prevalent Cases of Food Allergy (FA) based on Etiology-specific factors in United Kingdom (2018–2030)

Figure 20: Age-specific Prevalence of Food Allergy (FA) in the United Kingdom (2018–2030)

Figure 21: Prevalent cases of Food Allergy (FA) in Japan (2018–2030)

Figure 22: Prevalent Cases of Food Allergy (FA) based on Etiology-specific factors in Japan (2018–2030)

Figure 23: Age-specific Prevalence of Food Allergy (FA) in Japan (2018–2030)

Figure 24: 7 Major Market Size of Food Allergy (FA) in USD Million (2018–2030)

Figure 25: 7 Major Market Size of Food Allergy (FA) by Therapies in USD Million (2018–2030)

Figure 26: Market Size of Food Allergy (FA) in the United States, USD Million (2018–2030)

Figure 27: The United States Market Size of Food Allergy (FA) by Therapies in USD Million

Figure 28: Market Size of Food Allergy (FA) in the Germany, USD Million (2018–2030)

Figure 29: The Germany Market Size of Food Allergy (FA) by Therapies in USD Million (2018–2030)

Figure 30: Market Size of Food Allergy (FA) in the France, USD Million (2018–2030)

Figure 31: The France Market Size of Food Allergy (FA) by Therapies in USD Million (2018–2030)

Figure 32: Market Size of Food Allergy (FA) in the Italy, USD Million (2018–2030)

Figure 33: The Italy Market Size of Food Allergy (FA) by Therapies in USD Million (2018–2030)

Figure 34: Market Size of Food Allergy (FA) in the Spain, USD Million (2018–2030)

Figure 35: The Spain Market Size of Food Allergy (FA) by Therapies in USD Million

Figure 36: Market Size of Food Allergy (FA) in the United Kingdom, USD Million (2018–2030)

Figure 37: The United Kingdom Market Size of Food Allergy (FA) by Therapies in USD Million (2018–2030)

Figure 38: Market Size of Food Allergy (FA) in the Japan, USD Million (2018–2030)

Figure 39: The Japan Market Size of Food Allergy (FA) by Therapies in USD Million (2018–2030)

Forward to Friend

Need A Quote